Characterization of a highly attenuated Salmonella enterica serovar typhimurium mutant strain

Journal of Microbiology, Immunology and Infection

Volumn 35, Issue 4, 2002, Pages 229-235

  Tang, Ing Kae ^a,b   Ji, Dar Der ^a   Chou, Chi Fu ^a   Lin, Hung Chi ^a   Liao, Chin Len ^a   Sytwu, Huey Kang ^a   Wang, Jaang Jiun ^a   Liu, Yu Tien ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

Attenuation; Auxotrophic mutant; Immunogenicity; Salmonella enterica serovar Typhimurium

Indexed keywords

BACTERIAL VACCINE; TYPHOID VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; AUXOTROPHIC MUTANT; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM MUTANT; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; GENE STRUCTURE; IMMUNOGENICITY; INTESTINE LYMPHATIC TISSUE; LD 50; MOUSE; NONHUMAN; PHENOTYPE; SALMONELLA ENTERICA;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, BACTERIAL; CITRIC ACID; CYSTEINE; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; MUTATION; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; ULTRAVIOLET RAYS; VACCINES, ATTENUATED;

EID: 0036937657     PISSN: 02532662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ashcroft MT, Singh B, Nicholson CC, Ritchie JM, Sorryan E, Williams F. A seven year field trial of two typhoid vaccines in Guyana. Lancet 1967;2:1056-9.
2. Tapa S, Cvjetanovic B. Controlled field trial on the effectiveness of one and two doses of acetone-inactivated and dried typhoid vaccine. Bull WHO 1975;52:75-80.
3. Anonymous. A controlled field trial of the effectiveness of acetone-dried and inactivated and heat-phenol-inactivated typhoid vaccines in Yugoslavia. Bull WHO 1964;30:623-30.
4. Anonymous. Evaluation of typhoid vaccines in the laboratory and in a controlled field trial in Poland. Bull WHO 1965;32:15-27.
5. Collins FM. Vaccine and cell-mediated immunity. Bacteriol Rev 1974;38:371-402.
6. Collins FM, Mackaness GB, Blanden RV. Infection-immunity in experimental salmonellosis. J Exp Med 1966;124:601-19.
7. Asherson GL, Zembala M, Perera MA, Mayhew B, Thomas WR. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol 1977;33:145-55.
8. Bienenstock J, McDermott M, Befus D, O'Neill M. A common mucosal immunologic system involving the bronchus, breast, and bowel. Adv Exp Med Biol 1978;107:53-9.
9. Cebra JJ, Collins FM. Origin and differentiation of lymphocytes involved in the secretory IgA response. Cold Spring Harbor Symp Quant Biol 1976;41:201-15.
10. McCaughan G, Basten A. Immune system of the gastrointestinal tract. Int Rev Physiol 1983;28:131-57.
11. Nair R, Kamat RS. Effector cell-mediated immune response in mice immunized with Salmonella. J Med Microbiol 1982;15:215-21.
12. Carter PB, Collins FM. The route of enteric infection in normal mice. J Exp Med 1974;139:1189-203.
13. Cardenas L, Clements JD. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin Microbiol Rev 1992;5:328-42.
14. Chatfield S, Roberts M, Li J, Starns A, Dougan G. The use of live attenuated Salmonella typhimurium on the subsequent colonization of swine by the wild-type parent strain. Vet Microbiol 1994;31:207-20.
15. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and are effective live vaccines. Nature 1981;291:238-9.
16. Killar LM, Eisenstein TK. Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCr1BR mice; studies with an aromatic-dependent live S. typhimurium strain as a vaccine. Infect Immun 1985;47:605-12.
17. Maskell D, Sweeney K, Liew FY, Hormaeche C, Dougan G. Attenuated Salmonella typhimurium as live oral vaccines and carriers for delivering antigens to the secretory immune system. In: Chanock R, Lerner R, Brown F, eds. Vaccine 86. NewYork: Cold Spring Harbor Laboratory Press, 1986:213-6.
18. Maskell DJ, Sweeney KJ, O'Callaghan D, Hormaeche CE, Liew FY, Dougan G. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine systemic and secretory immune systems. Microb Pathogenesis 1987;2:211-21.
19. Linde K. Preparation of stable Salmonella vaccine strains through combination of 2 independently attenuating markers with no limitation on growth. Arch Exp Veterinarmed 1980;34:19-32.
20. O'Callaghan D, Maskell D, Liew FY, Easmon CSF, Dougan G. Characterization of aromatic and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect Immun 1998;56:419-23.
21. Sambrook J, Fritschj EF, Maniatis T, eds. Molecular cloning: A Laboratory Manual. 2nd ed. New York: Cold Spring Harbor Press; 1989.
22. Liu YT. Biosynthetic studies of amphotericins, candicidin, and nystatin by means of mutation. Proc Natl Sci Counc ROC (B) 1984;8:182-6.
23. Holliday R. A new method for the identification of biochemical mutants of microorganisms. Nature 1956;178:987.
24. Utley M, Franklin DP, Krogfelt KA, Laux DC, Cohen PS. A Salmonella typhimurium mutant unable to utilize fatty acids and citrate is avirulent and immunogenic in mice. FEMS Microbiol Lett 1998;163:129-34.
25. Reed LJ, Muench H. A simple method for estimating fifty percent endpoints. Am Hyg 1938;27:493-7.
26. Curtiss R, Kelly SM. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun 1987;55:3035-43.
27. Hormaeche CE. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 1979;37:311-8.
28. Mittrucker HW, Kohler A, Mak TW, Kaufmann SH. Critical role of CD28 in protective immunity against Salmonella typhimurium. J Immunol 1999;163:6769-76.
29. Pascopella L, Raupach B, Ghori N, Monack D, Falkow S, Samll PL. Host restriction phenotypes of Salmonella typhi and Salmonella gallinarum. Infect Immun 1995;63:4329-35.
30. Jones BD, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized M cells of the Peyer's patches. J Exp Med 1995;180:15-23.
31. Chen H, Chifferli DM. Mucosal and systemic immune responses to chimeric fimbriae expressed by Sabnonella entrica serovar Typhimurium vaccine strains. Infect Immun 2000;68:3129-39.
32. Nimmo HG. The tricarboxylic acid cycle and amplerotic reactions. In: Neidhardt FC, ed. Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology. Washington, DC: American Society for Microbiology; 1987:156-69.
33. Yokota T, Gots JS. Requirement of adenosine 3′,5′-cyclic phosphate for flagella formation in Escherichia coli and Salmonella typhimurium. J Bacteriol 1970;103:513-6.